Download these slides from a live symposium to learn more about targeting HER2, HER3, and TROP2 with antibody-drug conjugates in breast cancer.
Download these slides from a live symposium to learn more about targeting HER2 and TROP2 with antibody-drug conjugates in gastrointestinal cancers.
Download these slides from a live symposium to learn more about targeting HER2, HER3, and TROP2 with antibody-drug conjugates in non-small cell lung cancer.
In this on-demand webcast from a recent AACR satellite symposium, expert faculty highlight the latest evidence on the optimal use of HER2, HER3, and TROP2 antibody–drug conjugates in breast, gastrointestinal, and lung cancers.
Commentary by physician experts in breast, gastrointestinal, and lung cancers on key takeaways from a live symposium on HER2-, HER3-, and TROP2-targeted therapies and treatment approaches for patients.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.